SERMONIX PHARMACEUTICALS

Serial Number 88681480
Registration 7287506
700

Registration Progress

Application Filed
Nov 5, 2019
Under Examination
Dec 8, 2020
Approved for Publication
Oct 13, 2020
Published for Opposition
Oct 13, 2020
Registered
Jan 23, 2024

Trademark Image

SERMONIX PHARMACEUTICALS

Basic Information

Serial Number
88681480
Registration Number
7287506
Filing Date
November 5, 2019
Registration Date
January 23, 2024
Published for Opposition
October 13, 2020
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 23, 2024
Registration
Registered
Classes
005

Rights Holder

Sermonix Pharmaceuticals, Inc.

03
Address
250 East Broad Street, Suite 250
Columbus, OH 43215

Ownership History

Sermonix Pharmaceuticals, Inc.

Original Applicant
03
Columbus, OH

Sermonix Pharmaceuticals, Inc.

Owner at Publication
03
Columbus, OH

Sermonix Pharmaceuticals, Inc.

Original Registrant
03
Columbus, OH

Legal Representation

Attorney
Karen A. Webb, Esq.

USPTO Deadlines

Next Deadline
1454 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240123)
Due Date
January 23, 2030
Grace Period Ends
July 23, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Jan 23, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 23, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 19, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 16, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Nov 17, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 16, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 16, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 28, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 28, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Aug 28, 2023 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Jul 22, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 17, 2023 IUAF S USE AMENDMENT FILED Loading...
Jul 17, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 10, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 9, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 31, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Jun 9, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 31, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 17, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 15, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 13, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 13, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 13, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 11, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 11, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 11, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 29, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 27, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 27, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 27, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 4, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 2, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 2, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 2, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 8, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 4, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 4, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 4, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 8, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 13, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 13, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 23, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 8, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 6, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 6, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 6, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Sep 6, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 2, 2020 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Aug 25, 2020 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Aug 8, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...

Detailed Classifications

Class 005
Pharmaceutical preparation for post-menopausal women's health, namely, to prevent and treat breast cancer, osteoporosis and vulvovaginal atrophy
First Use Anywhere: Jun 20, 2023
First Use in Commerce: Jun 20, 2023

Additional Information

Design Mark
The mark consists of a series of nine circles in a vertical line next to a vertical line with another vertical line intersecting at the center, with a circle above, forming a geometric human figure, followed by the wording "SERMONIX PHARMACEUTICALS"
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"